THE US Food and Drug Administration (FDA) has announced funding for 21 new academia and industry clinical trial research grants totaling more than $23m over the next four years to develop products for patients with rare diseases, under the Orphan Products Research Grants Program.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Oct 16
